01—Abstract
Summary
Summary of the 10-Q filed April 23, 2015. Cited figures are marked; the original filing is the authoritative source.
Procter & Gamble's (PG) Q3 2015 filing shows a challenging quarter marked by a 8% year-over-year decline in net sales to $18.1 billiona, largely attributable to an unfavorable foreign exchange impact of 8% and a 2% decrease in unit volume.
Despite efforts to offset these headwinds through pricing and favorable product mix, the company experienced a 17% decrease in net earnings attributable to Procter & Gamble, reaching $2.2 billionb. This decline was exacerbated by a significant $308 million impairment charge related to the Batteries business, which is classified under discontinued operations. Operationally, the company is undergoing strategic portfolio optimization, highlighted by the planned divestiture of the Duracell business and the recent sale of its Pet Care operations.
While continuing operations saw a 2%c decline in net earnings, the company's organic sales growth remained flat for the quarter, indicating resilience in core product demand. Management's focus on productivity and cost savings continues, with significant restructuring charges incurred, aiming to improve long-term efficiency and fund growth initiatives. Investors should monitor the ongoing impact of foreign exchange rates and the successful execution of the portfolio transformation strategy.
02—Key points
Key Highlights
- Net sales for the third quarter decreased by 8% to $18.1 billion compared to the prior year, primarily driven by an 8% negative impact from foreign exchange and a 2% decline in unit volume.
- Net earnings attributable to Procter & Gamble declined significantly by 17% to $2.2 billion, impacted by foreign exchange, lower sales, and a $308 million impairment charge related to the Batteries business held for sale.
- Discontinued operations resulted in a net loss of $287 million for the quarter, primarily due to impairment charges on the Batteries business, compared to net earnings of $105 million in the prior year.
- Organic sales for continuing operations grew 1% for the quarter, indicating stable underlying demand despite overall sales declines.
- The company incurred $322 million in restructuring charges during the quarter as part of its ongoing productivity and cost savings plan.
- The Duracell business is planned for divestiture through a split transaction with Berkshire Hathaway, expected to close by the end of calendar 2015.
- Despite the challenging top-line performance, operating income margin for continuing operations improved by 50 basis points to 17.3%, driven by reduced SG&A as a percentage of sales.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2015, Procter & Gamble Co kept $0.13.
- Revenue$16.93B100.0%
- Cost of revenue−$8.93B52.7%
- Gross profit$8.00B47.3%
- Operating costs−$4.98B29.4%
- Operating income$3.02B17.9%
- Interest, other & tax−$872.0M5.2%
- Net income$2.15B12.7%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2015filed April 23, 2015Financial Statements
Q3 FY2015 against Q3 FY2014
| Line item | Q3 FY2015Q3 FY2014 | Change |
|---|---|---|
| Revenue | $16.93B$19.64B | −13.8% |
| Cost of Revenue | $8.93B$10.04B | −11.1% |
| Gross Profit | $8.00B$9.60B | −16.6% |
| SG&A Expenses | $4.98B$6.29B | −20.9% |
| Operating Income | $3.02B$3.31B | −8.5% |
| Interest Expense | $148.00M$180.00M | −17.8% |
| Net Income | $2.15B$2.61B | −17.5% |
| EPS (Basic) | $0.77$0.94 | −18.1% |
| EPS (Diluted) | $0.75$0.90 | −16.7% |
| Shares Outstanding (Basic) | 2.71B2.71B | −0.1% |
| Shares Outstanding (Diluted) | 2.88B2.89B | −0.4% |
05—Questions
Frequently Asked Questions
What is the primary reason for the decline in net sales?
The primary reasons for the decline in net sales are unfavorable foreign exchange movements, which reduced net sales by 8% for the quarter, and a 2% decrease in unit volume. While pricing and favorable product mix provided some offset, they were not enough to overcome these headwinds.
What is the significance of the impairment charge in discontinued operations?
The $308 million impairment charge in discontinued operations is related to the Batteries business, which is being divested. This charge reflects a decline in the estimated value of the Batteries business's goodwill and intangible assets, impacting the overall net earnings attributable to Procter & Gamble.
How is the company managing costs and improving efficiency?
Procter & Gamble is actively pursuing a productivity and cost savings plan, which includes significant restructuring charges. For the quarter, $322 million in restructuring costs were incurred. The company is focusing on manufacturing cost savings, marketing efficiencies, and overhead reductions to improve its cost structure and fund growth initiatives.
What is the outlook for the company's portfolio and future growth?
The company is undergoing a portfolio transformation, with plans to divest the Duracell business and having recently divested its Pet Care operations. Management aims to focus on core, higher-margin businesses. While organic sales for continuing operations showed some resilience, the overall outlook will depend on the successful execution of these divestitures, managing foreign exchange volatility, and driving innovation and growth in its remaining segments.
06—Continue